Drug Pricing Evolution in Hepatitis C Article Swipe
Nathalie Vernaz
,
François Girardin
,
Nicolas Goossens
,
Urs Brügger
,
Marco Riguzzi
,
Arnaud Perrier
,
Francesco Negro
·
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pone.0157098
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pone.0157098
The pricing of drugs for HCV regimens follows a value-based model, which has a stable ratio of costs per achieved SVR over 25 years. Health care systems are struggling with the high resource use of these new agents despite their obvious long-term advantages for the overall health of the population. Therefore, the pharmaceutical industry, health care payers and other stakeholders are challenged with finding new drug pricing schemes to treat the entire population infected with HCV.
Related Topics
Concepts
Telaprevir
Ombitasvir
Dasabuvir
Boceprevir
Sofosbuvir
Medicine
Ledipasvir
Paritaprevir
Internal medicine
Ribavirin
Ritonavir
Simeprevir
Regimen
Daclatasvir
Viral load
Hepatitis C virus
Virology
Virus
Antiretroviral therapy
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1371/journal.pone.0157098
- https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157098&type=printable
- OA Status
- gold
- Cited By
- 24
- References
- 51
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2433875347
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2433875347Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1371/journal.pone.0157098Digital Object Identifier
- Title
-
Drug Pricing Evolution in Hepatitis CWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2016Year of publication
- Publication date
-
2016-06-16Full publication date if available
- Authors
-
Nathalie Vernaz, François Girardin, Nicolas Goossens, Urs Brügger, Marco Riguzzi, Arnaud Perrier, Francesco NegroList of authors in order
- Landing page
-
https://doi.org/10.1371/journal.pone.0157098Publisher landing page
- PDF URL
-
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157098&type=printableDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157098&type=printableDirect OA link when available
- Concepts
-
Telaprevir, Ombitasvir, Dasabuvir, Boceprevir, Sofosbuvir, Medicine, Ledipasvir, Paritaprevir, Internal medicine, Ribavirin, Ritonavir, Simeprevir, Regimen, Daclatasvir, Viral load, Hepatitis C virus, Virology, Virus, Antiretroviral therapyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
24Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 2, 2021: 1, 2020: 6, 2019: 7, 2018: 3Per-year citation counts (last 5 years)
- References (count)
-
51Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2433875347 |
|---|---|
| doi | https://doi.org/10.1371/journal.pone.0157098 |
| ids.doi | https://doi.org/10.1371/journal.pone.0157098 |
| ids.mag | 2433875347 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/27310294 |
| ids.openalex | https://openalex.org/W2433875347 |
| fwci | 2.86966497 |
| mesh[0].qualifier_ui | Q000191 |
| mesh[0].descriptor_ui | D000998 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | economics |
| mesh[0].descriptor_name | Antiviral Agents |
| mesh[1].qualifier_ui | Q000627 |
| mesh[1].descriptor_ui | D000998 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | therapeutic use |
| mesh[1].descriptor_name | Antiviral Agents |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D003362 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Cost-Benefit Analysis |
| mesh[3].qualifier_ui | Q000191 |
| mesh[3].descriptor_ui | D055808 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | economics |
| mesh[3].descriptor_name | Drug Discovery |
| mesh[4].qualifier_ui | Q000191 |
| mesh[4].descriptor_ui | D004359 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | economics |
| mesh[4].descriptor_name | Drug Therapy, Combination |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D005838 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Genotype |
| mesh[6].qualifier_ui | Q000187 |
| mesh[6].descriptor_ui | D016174 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | drug effects |
| mesh[6].descriptor_name | Hepacivirus |
| mesh[7].qualifier_ui | Q000188 |
| mesh[7].descriptor_ui | D006526 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | drug therapy |
| mesh[7].descriptor_name | Hepatitis C |
| mesh[8].qualifier_ui | Q000191 |
| mesh[8].descriptor_ui | D006526 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | economics |
| mesh[8].descriptor_name | Hepatitis C |
| mesh[9].qualifier_ui | Q000453 |
| mesh[9].descriptor_ui | D006526 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | epidemiology |
| mesh[9].descriptor_name | Hepatitis C |
| mesh[10].qualifier_ui | Q000821 |
| mesh[10].descriptor_ui | D006526 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | virology |
| mesh[10].descriptor_name | Hepatitis C |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | Q000191 |
| mesh[12].descriptor_ui | D007372 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | economics |
| mesh[12].descriptor_name | Interferons |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D007372 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Interferons |
| mesh[14].qualifier_ui | Q000191 |
| mesh[14].descriptor_ui | D009842 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | economics |
| mesh[14].descriptor_name | Oligopeptides |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D009842 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Oligopeptides |
| mesh[16].qualifier_ui | Q000191 |
| mesh[16].descriptor_ui | D012254 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | economics |
| mesh[16].descriptor_name | Ribavirin |
| mesh[17].qualifier_ui | Q000627 |
| mesh[17].descriptor_ui | D012254 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | therapeutic use |
| mesh[17].descriptor_name | Ribavirin |
| mesh[18].qualifier_ui | Q000191 |
| mesh[18].descriptor_ui | D019438 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | economics |
| mesh[18].descriptor_name | Ritonavir |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D019438 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | Ritonavir |
| mesh[20].qualifier_ui | Q000191 |
| mesh[20].descriptor_ui | D000069474 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | economics |
| mesh[20].descriptor_name | Sofosbuvir |
| mesh[21].qualifier_ui | Q000627 |
| mesh[21].descriptor_ui | D000069474 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | therapeutic use |
| mesh[21].descriptor_name | Sofosbuvir |
| mesh[22].qualifier_ui | Q000453 |
| mesh[22].descriptor_ui | D013557 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | epidemiology |
| mesh[22].descriptor_name | Switzerland |
| mesh[23].qualifier_ui | Q000453 |
| mesh[23].descriptor_ui | D014481 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | epidemiology |
| mesh[23].descriptor_name | United States |
| mesh[24].qualifier_ui | Q000191 |
| mesh[24].descriptor_ui | D000998 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | economics |
| mesh[24].descriptor_name | Antiviral Agents |
| mesh[25].qualifier_ui | Q000627 |
| mesh[25].descriptor_ui | D000998 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | therapeutic use |
| mesh[25].descriptor_name | Antiviral Agents |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D003362 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Cost-Benefit Analysis |
| mesh[27].qualifier_ui | Q000191 |
| mesh[27].descriptor_ui | D055808 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | economics |
| mesh[27].descriptor_name | Drug Discovery |
| mesh[28].qualifier_ui | Q000191 |
| mesh[28].descriptor_ui | D004359 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | economics |
| mesh[28].descriptor_name | Drug Therapy, Combination |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D005838 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Genotype |
| mesh[30].qualifier_ui | Q000187 |
| mesh[30].descriptor_ui | D016174 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | drug effects |
| mesh[30].descriptor_name | Hepacivirus |
| mesh[31].qualifier_ui | Q000188 |
| mesh[31].descriptor_ui | D006526 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | drug therapy |
| mesh[31].descriptor_name | Hepatitis C |
| mesh[32].qualifier_ui | Q000191 |
| mesh[32].descriptor_ui | D006526 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | economics |
| mesh[32].descriptor_name | Hepatitis C |
| mesh[33].qualifier_ui | Q000453 |
| mesh[33].descriptor_ui | D006526 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | epidemiology |
| mesh[33].descriptor_name | Hepatitis C |
| mesh[34].qualifier_ui | Q000821 |
| mesh[34].descriptor_ui | D006526 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | virology |
| mesh[34].descriptor_name | Hepatitis C |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D006801 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Humans |
| mesh[36].qualifier_ui | Q000191 |
| mesh[36].descriptor_ui | D007372 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | economics |
| mesh[36].descriptor_name | Interferons |
| mesh[37].qualifier_ui | Q000627 |
| mesh[37].descriptor_ui | D007372 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | therapeutic use |
| mesh[37].descriptor_name | Interferons |
| mesh[38].qualifier_ui | Q000191 |
| mesh[38].descriptor_ui | D009842 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | economics |
| mesh[38].descriptor_name | Oligopeptides |
| mesh[39].qualifier_ui | Q000627 |
| mesh[39].descriptor_ui | D009842 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | therapeutic use |
| mesh[39].descriptor_name | Oligopeptides |
| mesh[40].qualifier_ui | Q000191 |
| mesh[40].descriptor_ui | D012254 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | economics |
| mesh[40].descriptor_name | Ribavirin |
| mesh[41].qualifier_ui | Q000627 |
| mesh[41].descriptor_ui | D012254 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | therapeutic use |
| mesh[41].descriptor_name | Ribavirin |
| mesh[42].qualifier_ui | Q000191 |
| mesh[42].descriptor_ui | D019438 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | economics |
| mesh[42].descriptor_name | Ritonavir |
| mesh[43].qualifier_ui | Q000627 |
| mesh[43].descriptor_ui | D019438 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | therapeutic use |
| mesh[43].descriptor_name | Ritonavir |
| mesh[44].qualifier_ui | Q000191 |
| mesh[44].descriptor_ui | D000069474 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | economics |
| mesh[44].descriptor_name | Sofosbuvir |
| mesh[45].qualifier_ui | Q000627 |
| mesh[45].descriptor_ui | D000069474 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | therapeutic use |
| mesh[45].descriptor_name | Sofosbuvir |
| mesh[46].qualifier_ui | Q000453 |
| mesh[46].descriptor_ui | D013557 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | epidemiology |
| mesh[46].descriptor_name | Switzerland |
| mesh[47].qualifier_ui | Q000453 |
| mesh[47].descriptor_ui | D014481 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | epidemiology |
| mesh[47].descriptor_name | United States |
| type | article |
| title | Drug Pricing Evolution in Hepatitis C |
| biblio.issue | 6 |
| biblio.volume | 11 |
| biblio.last_page | e0157098 |
| biblio.first_page | e0157098 |
| topics[0].id | https://openalex.org/T10151 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2721 |
| topics[0].subfield.display_name | Hepatology |
| topics[0].display_name | Hepatitis C virus research |
| topics[1].id | https://openalex.org/T10351 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9700999855995178 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Liver Disease Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T10308 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9557999968528748 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2745 |
| topics[2].subfield.display_name | Rheumatology |
| topics[2].display_name | Systemic Lupus Erythematosus Research |
| is_xpac | False |
| apc_list.value | 1805 |
| apc_list.currency | USD |
| apc_list.value_usd | 1805 |
| apc_paid.value | 1805 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1805 |
| concepts[0].id | https://openalex.org/C2778159067 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9080233573913574 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q408557 |
| concepts[0].display_name | Telaprevir |
| concepts[1].id | https://openalex.org/C2777100407 |
| concepts[1].level | 5 |
| concepts[1].score | 0.9068777561187744 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q19598175 |
| concepts[1].display_name | Ombitasvir |
| concepts[2].id | https://openalex.org/C2778785139 |
| concepts[2].level | 5 |
| concepts[2].score | 0.8675549030303955 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q19462214 |
| concepts[2].display_name | Dasabuvir |
| concepts[3].id | https://openalex.org/C2777159539 |
| concepts[3].level | 5 |
| concepts[3].score | 0.8047292232513428 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q410551 |
| concepts[3].display_name | Boceprevir |
| concepts[4].id | https://openalex.org/C2778390639 |
| concepts[4].level | 5 |
| concepts[4].score | 0.7668153047561646 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2502747 |
| concepts[4].display_name | Sofosbuvir |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.7656702995300293 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C2775999097 |
| concepts[6].level | 5 |
| concepts[6].score | 0.7546095848083496 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q15409409 |
| concepts[6].display_name | Ledipasvir |
| concepts[7].id | https://openalex.org/C2778867932 |
| concepts[7].level | 5 |
| concepts[7].score | 0.7529253959655762 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q16824572 |
| concepts[7].display_name | Paritaprevir |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.6107348799705505 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C2780040827 |
| concepts[9].level | 4 |
| concepts[9].score | 0.5552757978439331 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q421862 |
| concepts[9].display_name | Ribavirin |
| concepts[10].id | https://openalex.org/C2779298103 |
| concepts[10].level | 5 |
| concepts[10].score | 0.5464143753051758 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q422618 |
| concepts[10].display_name | Ritonavir |
| concepts[11].id | https://openalex.org/C2778986448 |
| concepts[11].level | 5 |
| concepts[11].score | 0.5245469212532043 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7517689 |
| concepts[11].display_name | Simeprevir |
| concepts[12].id | https://openalex.org/C2781413609 |
| concepts[12].level | 2 |
| concepts[12].score | 0.5210851430892944 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7308373 |
| concepts[12].display_name | Regimen |
| concepts[13].id | https://openalex.org/C2776979040 |
| concepts[13].level | 5 |
| concepts[13].score | 0.4653080105781555 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q5207712 |
| concepts[13].display_name | Daclatasvir |
| concepts[14].id | https://openalex.org/C142462285 |
| concepts[14].level | 3 |
| concepts[14].score | 0.3254799246788025 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q2528140 |
| concepts[14].display_name | Viral load |
| concepts[15].id | https://openalex.org/C2776408679 |
| concepts[15].level | 3 |
| concepts[15].score | 0.3238028287887573 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q708693 |
| concepts[15].display_name | Hepatitis C virus |
| concepts[16].id | https://openalex.org/C159047783 |
| concepts[16].level | 1 |
| concepts[16].score | 0.2864605784416199 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[16].display_name | Virology |
| concepts[17].id | https://openalex.org/C2522874641 |
| concepts[17].level | 2 |
| concepts[17].score | 0.07822316884994507 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[17].display_name | Virus |
| concepts[18].id | https://openalex.org/C2993143319 |
| concepts[18].level | 4 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q583050 |
| concepts[18].display_name | Antiretroviral therapy |
| keywords[0].id | https://openalex.org/keywords/telaprevir |
| keywords[0].score | 0.9080233573913574 |
| keywords[0].display_name | Telaprevir |
| keywords[1].id | https://openalex.org/keywords/ombitasvir |
| keywords[1].score | 0.9068777561187744 |
| keywords[1].display_name | Ombitasvir |
| keywords[2].id | https://openalex.org/keywords/dasabuvir |
| keywords[2].score | 0.8675549030303955 |
| keywords[2].display_name | Dasabuvir |
| keywords[3].id | https://openalex.org/keywords/boceprevir |
| keywords[3].score | 0.8047292232513428 |
| keywords[3].display_name | Boceprevir |
| keywords[4].id | https://openalex.org/keywords/sofosbuvir |
| keywords[4].score | 0.7668153047561646 |
| keywords[4].display_name | Sofosbuvir |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.7656702995300293 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/ledipasvir |
| keywords[6].score | 0.7546095848083496 |
| keywords[6].display_name | Ledipasvir |
| keywords[7].id | https://openalex.org/keywords/paritaprevir |
| keywords[7].score | 0.7529253959655762 |
| keywords[7].display_name | Paritaprevir |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.6107348799705505 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/ribavirin |
| keywords[9].score | 0.5552757978439331 |
| keywords[9].display_name | Ribavirin |
| keywords[10].id | https://openalex.org/keywords/ritonavir |
| keywords[10].score | 0.5464143753051758 |
| keywords[10].display_name | Ritonavir |
| keywords[11].id | https://openalex.org/keywords/simeprevir |
| keywords[11].score | 0.5245469212532043 |
| keywords[11].display_name | Simeprevir |
| keywords[12].id | https://openalex.org/keywords/regimen |
| keywords[12].score | 0.5210851430892944 |
| keywords[12].display_name | Regimen |
| keywords[13].id | https://openalex.org/keywords/daclatasvir |
| keywords[13].score | 0.4653080105781555 |
| keywords[13].display_name | Daclatasvir |
| keywords[14].id | https://openalex.org/keywords/viral-load |
| keywords[14].score | 0.3254799246788025 |
| keywords[14].display_name | Viral load |
| keywords[15].id | https://openalex.org/keywords/hepatitis-c-virus |
| keywords[15].score | 0.3238028287887573 |
| keywords[15].display_name | Hepatitis C virus |
| keywords[16].id | https://openalex.org/keywords/virology |
| keywords[16].score | 0.2864605784416199 |
| keywords[16].display_name | Virology |
| keywords[17].id | https://openalex.org/keywords/virus |
| keywords[17].score | 0.07822316884994507 |
| keywords[17].display_name | Virus |
| language | en |
| locations[0].id | doi:10.1371/journal.pone.0157098 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S202381698 |
| locations[0].source.issn | 1932-6203 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1932-6203 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | PLoS ONE |
| locations[0].source.host_organization | https://openalex.org/P4310315706 |
| locations[0].source.host_organization_name | Public Library of Science |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315706 |
| locations[0].source.host_organization_lineage_names | Public Library of Science |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157098&type=printable |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | PLOS ONE |
| locations[0].landing_page_url | https://doi.org/10.1371/journal.pone.0157098 |
| locations[1].id | pmid:27310294 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | PloS one |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/27310294 |
| locations[2].id | pmh:oai:unige.ch:aou:unige:84841 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306402259 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Archive ouverte UNIGE (University of Geneva) |
| locations[2].source.host_organization | https://openalex.org/I114457229 |
| locations[2].source.host_organization_name | University of Geneva |
| locations[2].source.host_organization_lineage | https://openalex.org/I114457229 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | publishedVersion |
| locations[2].raw_type | info:eu-repo/semantics/article |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | True |
| locations[2].is_published | True |
| locations[2].raw_source_name | ISSN: 1932-6203 |
| locations[2].landing_page_url | https://archive-ouverte.unige.ch/unige:84841 |
| locations[3].id | pmh:oai:www.zora.uzh.ch:251660 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401281 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Zurich Open Repository and Archive (University of Zurich) |
| locations[3].source.host_organization | https://openalex.org/I202697423 |
| locations[3].source.host_organization_name | University of Zurich |
| locations[3].source.host_organization_lineage | https://openalex.org/I202697423 |
| locations[3].license | cc-by |
| locations[3].pdf_url | |
| locations[3].version | publishedVersion |
| locations[3].raw_type | info:eu-repo/semantics/publishedVersion |
| locations[3].license_id | https://openalex.org/licenses/cc-by |
| locations[3].is_accepted | True |
| locations[3].is_published | True |
| locations[3].raw_source_name | Vernaz, Nathalie; Girardin, François; Goossens, Nicolas; Brügger, Urs; Riguzzi, Marco; Perrier, Arnaud; Negro, Francesco (2016). Drug Pricing Evolution in Hepatitis C. PLoS ONE, 11(6):e0157098. |
| locations[3].landing_page_url | |
| locations[4].id | pmh:oai:RePEc:plo:pone00:0157098 |
| locations[4].is_oa | False |
| locations[4].source.id | https://openalex.org/S4306401271 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | RePEc: Research Papers in Economics |
| locations[4].source.host_organization | https://openalex.org/I77793887 |
| locations[4].source.host_organization_name | Federal Reserve Bank of St. Louis |
| locations[4].source.host_organization_lineage | https://openalex.org/I77793887 |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157098 |
| locations[5].id | pmh:oai:digitalcollection.zhaw.ch:11475/12886 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S4306401810 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences) |
| locations[5].source.host_organization | https://openalex.org/I200744771 |
| locations[5].source.host_organization_name | ZHAW Zurich University of Applied Sciences |
| locations[5].source.host_organization_lineage | https://openalex.org/I200744771 |
| locations[5].license | cc-by |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | Text |
| locations[5].license_id | https://openalex.org/licenses/cc-by |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | |
| locations[5].landing_page_url | https://digitalcollection.zhaw.ch/handle/11475/12886 |
| locations[6].id | pmh:oai:doaj.org/article:b613fa0edb25491597a92b561f6c00fe |
| locations[6].is_oa | True |
| locations[6].source.id | https://openalex.org/S4306401280 |
| locations[6].source.issn | |
| locations[6].source.type | repository |
| locations[6].source.is_oa | False |
| locations[6].source.issn_l | |
| locations[6].source.is_core | False |
| locations[6].source.is_in_doaj | False |
| locations[6].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[6].source.host_organization | |
| locations[6].source.host_organization_name | |
| locations[6].license | cc-by-sa |
| locations[6].pdf_url | |
| locations[6].version | submittedVersion |
| locations[6].raw_type | article |
| locations[6].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[6].is_accepted | False |
| locations[6].is_published | False |
| locations[6].raw_source_name | PLoS ONE, Vol 11, Iss 6, p e0157098 (2016) |
| locations[6].landing_page_url | https://doaj.org/article/b613fa0edb25491597a92b561f6c00fe |
| locations[7].id | pmh:oai:europepmc.org:3899911 |
| locations[7].is_oa | True |
| locations[7].source.id | https://openalex.org/S4306400806 |
| locations[7].source.issn | |
| locations[7].source.type | repository |
| locations[7].source.is_oa | False |
| locations[7].source.issn_l | |
| locations[7].source.is_core | False |
| locations[7].source.is_in_doaj | False |
| locations[7].source.display_name | Europe PMC (PubMed Central) |
| locations[7].source.host_organization | https://openalex.org/I1303153112 |
| locations[7].source.host_organization_name | European Bioinformatics Institute |
| locations[7].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[7].license | cc-by |
| locations[7].pdf_url | |
| locations[7].version | submittedVersion |
| locations[7].raw_type | Text |
| locations[7].license_id | https://openalex.org/licenses/cc-by |
| locations[7].is_accepted | False |
| locations[7].is_published | False |
| locations[7].raw_source_name | |
| locations[7].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/4911078 |
| locations[8].id | pmh:oai:pubmedcentral.nih.gov:4911078 |
| locations[8].is_oa | True |
| locations[8].source.id | https://openalex.org/S2764455111 |
| locations[8].source.issn | |
| locations[8].source.type | repository |
| locations[8].source.is_oa | False |
| locations[8].source.issn_l | |
| locations[8].source.is_core | False |
| locations[8].source.is_in_doaj | False |
| locations[8].source.display_name | PubMed Central |
| locations[8].source.host_organization | https://openalex.org/I1299303238 |
| locations[8].source.host_organization_name | National Institutes of Health |
| locations[8].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[8].license | cc-by |
| locations[8].pdf_url | |
| locations[8].version | submittedVersion |
| locations[8].raw_type | Text |
| locations[8].license_id | https://openalex.org/licenses/cc-by |
| locations[8].is_accepted | False |
| locations[8].is_published | False |
| locations[8].raw_source_name | |
| locations[8].landing_page_url | http://doi.org/10.1371/journal.pone.0157098 |
| locations[9].id | doi:10.21256/zhaw-4045 |
| locations[9].is_oa | True |
| locations[9].source.id | https://openalex.org/S7407051289 |
| locations[9].source.type | repository |
| locations[9].source.is_oa | False |
| locations[9].source.issn_l | |
| locations[9].source.is_core | False |
| locations[9].source.is_in_doaj | False |
| locations[9].source.display_name | ZHAW Digital Collection |
| locations[9].source.host_organization | |
| locations[9].source.host_organization_name | |
| locations[9].license | cc-by |
| locations[9].pdf_url | |
| locations[9].version | |
| locations[9].raw_type | article-journal |
| locations[9].license_id | https://openalex.org/licenses/cc-by |
| locations[9].is_accepted | False |
| locations[9].is_published | |
| locations[9].raw_source_name | |
| locations[9].landing_page_url | https://doi.org/10.21256/zhaw-4045 |
| locations[10].id | doi:10.5167/uzh-251660 |
| locations[10].is_oa | True |
| locations[10].source.id | https://openalex.org/S7407051291 |
| locations[10].source.type | repository |
| locations[10].source.is_oa | False |
| locations[10].source.issn_l | |
| locations[10].source.is_core | False |
| locations[10].source.is_in_doaj | False |
| locations[10].source.display_name | Universität Zürich, ZORA |
| locations[10].source.host_organization | |
| locations[10].source.host_organization_name | |
| locations[10].license | |
| locations[10].pdf_url | |
| locations[10].version | |
| locations[10].raw_type | article-journal |
| locations[10].license_id | |
| locations[10].is_accepted | False |
| locations[10].is_published | |
| locations[10].raw_source_name | |
| locations[10].landing_page_url | https://doi.org/10.5167/uzh-251660 |
| indexed_in | crossref, datacite, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5014137670 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1371-5510 |
| authorships[0].author.display_name | Nathalie Vernaz |
| authorships[0].countries | CH |
| authorships[0].affiliations[0].raw_affiliation_string | Finance Direction, Geneva University Hospitals, Geneva, Switzerland |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I114457229 |
| authorships[0].affiliations[1].raw_affiliation_string | Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[0].institutions[0].id | https://openalex.org/I114457229 |
| authorships[0].institutions[0].ror | https://ror.org/01swzsf04 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I114457229 |
| authorships[0].institutions[0].country_code | CH |
| authorships[0].institutions[0].display_name | University of Geneva |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nathalie Vernaz |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Finance Direction, Geneva University Hospitals, Geneva, Switzerland, Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[1].author.id | https://openalex.org/A5038941155 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0842-927X |
| authorships[1].author.display_name | François Girardin |
| authorships[1].countries | CH |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I114457229 |
| authorships[1].affiliations[0].raw_affiliation_string | Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I114457229 |
| authorships[1].affiliations[1].raw_affiliation_string | Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[1].institutions[0].id | https://openalex.org/I114457229 |
| authorships[1].institutions[0].ror | https://ror.org/01swzsf04 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I114457229 |
| authorships[1].institutions[0].country_code | CH |
| authorships[1].institutions[0].display_name | University of Geneva |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | François Girardin |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland, Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[2].author.id | https://openalex.org/A5083740630 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8698-4690 |
| authorships[2].author.display_name | Nicolas Goossens |
| authorships[2].countries | CH |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I114457229 |
| authorships[2].affiliations[0].raw_affiliation_string | Divisions of Gastroenterology and Hepatology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[2].institutions[0].id | https://openalex.org/I114457229 |
| authorships[2].institutions[0].ror | https://ror.org/01swzsf04 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I114457229 |
| authorships[2].institutions[0].country_code | CH |
| authorships[2].institutions[0].display_name | University of Geneva |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Nicolas Goossens |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Divisions of Gastroenterology and Hepatology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[3].author.id | https://openalex.org/A5012598088 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Urs Brügger |
| authorships[3].countries | CH |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I858936495 |
| authorships[3].affiliations[0].raw_affiliation_string | Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland |
| authorships[3].institutions[0].id | https://openalex.org/I858936495 |
| authorships[3].institutions[0].ror | https://ror.org/05pmsvm27 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I858936495 |
| authorships[3].institutions[0].country_code | CH |
| authorships[3].institutions[0].display_name | ZHAW Zurich University of Applied Sciences |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Urs Brügger |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland |
| authorships[4].author.id | https://openalex.org/A5077691270 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3056-351X |
| authorships[4].author.display_name | Marco Riguzzi |
| authorships[4].countries | CH |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I858936495 |
| authorships[4].affiliations[0].raw_affiliation_string | Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland |
| authorships[4].institutions[0].id | https://openalex.org/I858936495 |
| authorships[4].institutions[0].ror | https://ror.org/05pmsvm27 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I858936495 |
| authorships[4].institutions[0].country_code | CH |
| authorships[4].institutions[0].display_name | ZHAW Zurich University of Applied Sciences |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Marco Riguzzi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland |
| authorships[5].author.id | https://openalex.org/A5062867494 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5549-8609 |
| authorships[5].author.display_name | Arnaud Perrier |
| authorships[5].countries | CH |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I114457229 |
| authorships[5].affiliations[0].raw_affiliation_string | Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I114457229 |
| authorships[5].affiliations[1].raw_affiliation_string | Division of General Internal Medicine, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[5].institutions[0].id | https://openalex.org/I114457229 |
| authorships[5].institutions[0].ror | https://ror.org/01swzsf04 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I114457229 |
| authorships[5].institutions[0].country_code | CH |
| authorships[5].institutions[0].display_name | University of Geneva |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Arnaud Perrier |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of General Internal Medicine, Geneva University Hospitals, University of Geneva, Geneva, Switzerland, Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland |
| authorships[6].author.id | https://openalex.org/A5026722725 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-4046-4806 |
| authorships[6].author.display_name | Francesco Negro |
| authorships[6].countries | CH |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210106256 |
| authorships[6].affiliations[0].raw_affiliation_string | Divisions of Gastroenterology and Hepatology and of Clinical Pathology, Geneva University Hospitals, Geneva, Switzerland |
| authorships[6].institutions[0].id | https://openalex.org/I4210106256 |
| authorships[6].institutions[0].ror | https://ror.org/01m1pv723 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210106256 |
| authorships[6].institutions[0].country_code | CH |
| authorships[6].institutions[0].display_name | University Hospital of Geneva |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Francesco Negro |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Divisions of Gastroenterology and Hepatology and of Clinical Pathology, Geneva University Hospitals, Geneva, Switzerland |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157098&type=printable |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Drug Pricing Evolution in Hepatitis C |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10151 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2721 |
| primary_topic.subfield.display_name | Hepatology |
| primary_topic.display_name | Hepatitis C virus research |
| related_works | https://openalex.org/W2565807151, https://openalex.org/W1952164093, https://openalex.org/W2398146970, https://openalex.org/W2462092081, https://openalex.org/W2216962669, https://openalex.org/W2888101277, https://openalex.org/W1881020383, https://openalex.org/W3145001265, https://openalex.org/W1239121778, https://openalex.org/W2128498309 |
| cited_by_count | 24 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2021 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2020 |
| counts_by_year[2].cited_by_count | 6 |
| counts_by_year[3].year | 2019 |
| counts_by_year[3].cited_by_count | 7 |
| counts_by_year[4].year | 2018 |
| counts_by_year[4].cited_by_count | 3 |
| counts_by_year[5].year | 2017 |
| counts_by_year[5].cited_by_count | 2 |
| counts_by_year[6].year | 2016 |
| counts_by_year[6].cited_by_count | 3 |
| locations_count | 11 |
| best_oa_location.id | doi:10.1371/journal.pone.0157098 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S202381698 |
| best_oa_location.source.issn | 1932-6203 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1932-6203 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | PLoS ONE |
| best_oa_location.source.host_organization | https://openalex.org/P4310315706 |
| best_oa_location.source.host_organization_name | Public Library of Science |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| best_oa_location.source.host_organization_lineage_names | Public Library of Science |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157098&type=printable |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | PLOS ONE |
| best_oa_location.landing_page_url | https://doi.org/10.1371/journal.pone.0157098 |
| primary_location.id | doi:10.1371/journal.pone.0157098 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S202381698 |
| primary_location.source.issn | 1932-6203 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1932-6203 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | PLoS ONE |
| primary_location.source.host_organization | https://openalex.org/P4310315706 |
| primary_location.source.host_organization_name | Public Library of Science |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315706 |
| primary_location.source.host_organization_lineage_names | Public Library of Science |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157098&type=printable |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | PLOS ONE |
| primary_location.landing_page_url | https://doi.org/10.1371/journal.pone.0157098 |
| publication_date | 2016-06-16 |
| publication_year | 2016 |
| referenced_works | https://openalex.org/W1502488305, https://openalex.org/W6684015116, https://openalex.org/W6646870017, https://openalex.org/W2156574153, https://openalex.org/W2127685726, https://openalex.org/W2125963799, https://openalex.org/W2143559032, https://openalex.org/W1841961054, https://openalex.org/W2077397479, https://openalex.org/W2113428683, https://openalex.org/W2081897332, https://openalex.org/W2078251659, https://openalex.org/W2043193067, https://openalex.org/W2143244227, https://openalex.org/W2127189337, https://openalex.org/W1980771473, https://openalex.org/W6661606482, https://openalex.org/W1943184652, https://openalex.org/W2121175754, https://openalex.org/W7073629828, https://openalex.org/W6644722089, https://openalex.org/W2165404326, https://openalex.org/W1515360100, https://openalex.org/W2147744539, https://openalex.org/W6662173462, https://openalex.org/W2141317928, https://openalex.org/W2092646281, https://openalex.org/W2057503746, https://openalex.org/W2113756727, https://openalex.org/W2156998092, https://openalex.org/W1569419857, https://openalex.org/W2145409766, https://openalex.org/W2078799829, https://openalex.org/W2097068106, https://openalex.org/W2144171787, https://openalex.org/W7073537829, https://openalex.org/W6685748298, https://openalex.org/W1996011908, https://openalex.org/W2004468849, https://openalex.org/W1510872982, https://openalex.org/W1979753504, https://openalex.org/W2175038046, https://openalex.org/W1986725099, https://openalex.org/W2045527310, https://openalex.org/W2044534476, https://openalex.org/W4249894549, https://openalex.org/W2181792533, https://openalex.org/W1978880915, https://openalex.org/W2060918723, https://openalex.org/W1745658487, https://openalex.org/W2163606686 |
| referenced_works_count | 51 |
| abstract_inverted_index.a | 8, 13 |
| abstract_inverted_index.25 | 22 |
| abstract_inverted_index.of | 2, 16, 34, 47 |
| abstract_inverted_index.to | 68 |
| abstract_inverted_index.HCV | 5 |
| abstract_inverted_index.SVR | 20 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.and | 57 |
| abstract_inverted_index.are | 27, 60 |
| abstract_inverted_index.for | 4, 43 |
| abstract_inverted_index.has | 12 |
| abstract_inverted_index.new | 36, 64 |
| abstract_inverted_index.per | 18 |
| abstract_inverted_index.the | 30, 44, 48, 51, 70 |
| abstract_inverted_index.use | 33 |
| abstract_inverted_index.HCV. | 75 |
| abstract_inverted_index.care | 25, 55 |
| abstract_inverted_index.drug | 65 |
| abstract_inverted_index.high | 31 |
| abstract_inverted_index.over | 21 |
| abstract_inverted_index.with | 29, 62, 74 |
| abstract_inverted_index.costs | 17 |
| abstract_inverted_index.drugs | 3 |
| abstract_inverted_index.other | 58 |
| abstract_inverted_index.ratio | 15 |
| abstract_inverted_index.their | 39 |
| abstract_inverted_index.these | 35 |
| abstract_inverted_index.treat | 69 |
| abstract_inverted_index.which | 11 |
| abstract_inverted_index.Health | 24 |
| abstract_inverted_index.agents | 37 |
| abstract_inverted_index.entire | 71 |
| abstract_inverted_index.health | 46, 54 |
| abstract_inverted_index.model, | 10 |
| abstract_inverted_index.payers | 56 |
| abstract_inverted_index.stable | 14 |
| abstract_inverted_index.years. | 23 |
| abstract_inverted_index.despite | 38 |
| abstract_inverted_index.finding | 63 |
| abstract_inverted_index.follows | 7 |
| abstract_inverted_index.obvious | 40 |
| abstract_inverted_index.overall | 45 |
| abstract_inverted_index.pricing | 1, 66 |
| abstract_inverted_index.schemes | 67 |
| abstract_inverted_index.systems | 26 |
| abstract_inverted_index.achieved | 19 |
| abstract_inverted_index.infected | 73 |
| abstract_inverted_index.regimens | 6 |
| abstract_inverted_index.resource | 32 |
| abstract_inverted_index.industry, | 53 |
| abstract_inverted_index.long-term | 41 |
| abstract_inverted_index.Therefore, | 50 |
| abstract_inverted_index.advantages | 42 |
| abstract_inverted_index.challenged | 61 |
| abstract_inverted_index.population | 72 |
| abstract_inverted_index.struggling | 28 |
| abstract_inverted_index.population. | 49 |
| abstract_inverted_index.value-based | 9 |
| abstract_inverted_index.stakeholders | 59 |
| abstract_inverted_index.pharmaceutical | 52 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5014137670 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I114457229 |
| citation_normalized_percentile.value | 0.90920737 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |